CDK5 and breast cancer: In addition, phosphorylation of GIV by Cdk5 is to play a role in the migration‐proliferation dichotomy,7 and in breast cancer, Cdk5 phosphorylation of adducin‐1 is important for epidermal growth factor‐induced cell migration and invasion.8